In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
134 News Items found
A researcher working in an MSK lab
MSK Research Highlights, March 3, 2025

New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.
Illustration of Enterococcus
Finding
Study in Mice Suggests Lactose in the Diet Feeds Dangerous Gut Bacteria When the Immune System Is Compromised

Lab mice who had lactose removed from their diets had a decreased risk of infection with the Enterococcus bacterium.
Memorial Sloan Kettering medical oncologist Andrea Cercek
In the Clinic
FDA Approval Gives Hope to Some People with Advanced Colorectal Cancer

A new treatment is approved for an especially aggressive kind of colorectal cancer.
In this fluorescent microscopy image of endoderm tissue from a mouse embryo, cell membranes are red, cell nuclei are blue, and extra-embryonic endoderm cells are green (they appear turquoise because blue and green are merged).
In the Lab
Scientists Rewrite the Textbook of Organ Development, One Cell at a Time

A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
Reicy Bobadilla stands in front of a window with the MSK logo on it
What You Should Know About Mesothelioma in Younger Patients

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.
Rihanna sitting in a chair outside
Feature
Getting to the Root of Pediatric Cancers

MSK Kids is leading a major effort to fully deliver on the promise of precision medicine for our youngest patients.
Scott Lowe
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Patient Story
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as Doctor

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.